Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade.
Shekarian T, Sivado E, Jallas AC, Depil S, Kielbassa J, Janoueix-Lerosey I, Hutter G, Goutagny N, Bergeron C, Viari A, Valsesia-Wittmann S, Caux C, Marabelle A.
Shekarian T, et al. Among authors: jallas ac.
Sci Transl Med. 2019 Oct 23;11(515):eaat5025. doi: 10.1126/scitranslmed.aat5025.
Sci Transl Med. 2019.
PMID: 31645452